Influence of LH-RH agonists on the growth and hormonal environment of breast and prostate cancer.
Patients with advanced breast cancer or advanced prostate cancer have been treated with an LH-RH-agonist ICI 118630. A chemical castration-like response has been achieved in all patients and is associated with clinical remission of the disease.